Moreover, the inhibition of mTORC2 by several ATP-competitive mTOR kinase inhibitors and RICTOR/mTORC2 depletion could decrease the cell growth, proliferation, motility, invasiveness, and stemness properties of GBM cells and malignant glioma tumors22–25. Here, RICTOR is linked to glioblastoma.